Home/Filings/4/0001683168-18-003617
4//SEC Filing

Garnette Sophia 4

Accession 0001683168-18-003617

CIK 0001355790other

Filed

Dec 5, 7:00 PM ET

Accepted

Dec 6, 7:59 AM ET

Size

12.6 KB

Accession

0001683168-18-003617

Insider Transaction Report

Form 4
Period: 2018-12-04
Bakalova Sofya
Dir. of Legal Affairs & Oper.
Transactions
  • Exercise/Conversion

    Common Stock

    2018-12-04$1.09/sh+2,778$3,0283,045 total
  • Sale

    Common Stock

    2018-12-04$1.54/sh10,636$16,379267 total
  • Exercise/Conversion

    Common Stock

    2018-12-04$1.10/sh+7,858$8,64410,903 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-12-042,7788,333 total
    Exercise: $1.09Exp: 2027-02-10Common Stock (11,111 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-12-047,85840,273 total
    Exercise: $1.10Exp: 2027-05-31Common Stock (47,858 underlying)
Footnotes (3)
  • [F1]The reported shares were sold in open market transactions through a broker-dealer at $1.54 per share.
  • [F2]The option, representing a total of 20,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on May 10, 2017, and the remaining shares in equal monthly installments over a period of 33 months.
  • [F3]The option, representing a total of 60,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on August 31, 2017, and the remaining shares in equal monthly installments over a period of 33 months.

Documents

1 file

Issuer

International Stem Cell CORP

CIK 0001355790

Entity typeother

Related Parties

1
  • filerCIK 0001616590

Filing Metadata

Form type
4
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 7:59 AM ET
Size
12.6 KB